ECGI Holdings Inc (ECGI)

[Potse]

breccia...RM structure, price target, etc......

I believe the timeframe for taking ECG public is 2015. I am guessing picking up a clean shell on the down low and acquiring as many shares as possible would make sense in a RM situation. I'm sure ECG would require equity, hard to tell what that would look like.

I checked out the other companies Bentivoglio took public.. not all of them had great success from a sharepoint point of view. I wouldn't get too excited for $1/share... not to say it can't happen.

I haven't sold any of my SUIP position yet, as my personal target price is somewhere around the 20-40+ cent area sometime between now and about mid-2015 or so. Given how difficult it has been at various times to accumulate a large position in this shell I figure it might be wise for me to maintain a sizable position now for potentially better selling opportunities in the future.

I'm not sure what the time frame on a possible SUIP/ECG reverse merger would be. If Event Cardio Group is the RM target, I am assuming Bentivoglio would probably want to have the RM fully completed prior to ECG filing its marketing applications in the United States and Canada. Depending on market conditions and stock specific situations, medical device filings for marketing approval/clearance can result in some explosive/momentum types of runs on stocks. Based on the article below, it looks like ECG expects to make those filings sometime during 2015.....

http://www.niagarahealthday.com/presenter-nicholas-bozza/

There are a number of factors that would affect what the SUIP RM share structure would look like: pre/post RM dilution, financings, etc. But generally speaking, most RM deals are initially structured in such a fashion that the retail investors retain roughly a 5-10% ownership (give or take a few percentage points).

Assuming no (or very little) pre-RM dilution, and given the above "normal" parameters for a RM, I am anticipating that the initial SUIP RM share structure would probably have somewhere around 70-140M shares outstanding. If Bentivoglio were to include his 1.4M shares as part of the ECG consideration, the share structure would be somewhere around 55-110M shares.

Bad financings or unattractive consultant agreements could always make this a moot point, but one thing that I found a little bit curious/interesting (based on his LinkedIn profile) is that Bentivoglio appears to be somewhat more intimately involved in ECG than some of the other stocks/investments he has been in. That could be a good sign for retail investors in SUIP, but that remains to be seen until things develop more fully.